Amundi Grows Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Amundi raised its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 199.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 40,954 shares of the company's stock after buying an additional 27,288 shares during the quarter. Amundi's holdings in Pediatrix Medical Group were worth $521,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of MD. Pacer Advisors Inc. bought a new stake in Pediatrix Medical Group during the fourth quarter valued at $35,492,000. Weiss Asset Management LP boosted its position in shares of Pediatrix Medical Group by 50.5% during the 3rd quarter. Weiss Asset Management LP now owns 912,818 shares of the company's stock valued at $10,580,000 after acquiring an additional 306,143 shares during the last quarter. Raymond James Financial Inc. purchased a new position in shares of Pediatrix Medical Group during the fourth quarter worth about $3,066,000. RBF Capital LLC bought a new position in shares of Pediatrix Medical Group in the third quarter worth approximately $1,695,000. Finally, Rubric Capital Management LP raised its stake in Pediatrix Medical Group by 1.5% in the third quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company's stock valued at $95,907,000 after purchasing an additional 125,000 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Trading Up 2.1 %

NYSE:MD traded up $0.30 during mid-day trading on Monday, reaching $14.51. 593,809 shares of the company's stock traded hands, compared to its average volume of 811,255. The company has a 50 day moving average price of $14.31 and a 200-day moving average price of $13.55. Pediatrix Medical Group, Inc. has a 12-month low of $6.62 and a 12-month high of $17.67. The firm has a market capitalization of $1.25 billion, a price-to-earnings ratio of -12.09, a PEG ratio of 1.74 and a beta of 1.49. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42.

Remove Ads

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The business had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. On average, sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on MD. Macquarie started coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an "outperform" rating and a $18.00 price target on the stock. UBS Group raised their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research report on Friday, February 21st. StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Finally, Truist Financial raised their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a research note on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, Pediatrix Medical Group has a consensus rating of "Hold" and an average target price of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.